GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview. 

Ultrafast MCE could go on to become a go-to treatment option for obstructive coronary artery disease, according to the authors of a new first-in-human clinical study.

Elucid's PlaqueIQ was trained to turn CCTA images into interactive 3D reports that help physicians visualize the presence of atherosclerosis.

It allows providers to quantify changes in tumor size throughout patients’ treatment in real-time, providing early indications of efficacy and enabling adjustments as needed.

New research suggests that treatment regimens can be nearly halved without increasing the risk of recurrence or complications further down the road. 

As part of efforts to address staffing shortages, the American Society of Radiologic Technologists is holding a virtual career fair focused on radiation therapy jobs on Sept. 26.

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated. 

The vest offers extended coverage of the breast, axilla and thyroid. It is said to reduce exposure of these areas by nearly 98%.